General Information of This Antigen
Antigen ID
TAR0LXDND
Antigen Name
Lymphocyte antigen 6E (LY6E)
Gene Name
LY6E
Synonym
Retinoic acid-induced gene E protein;Stem cell antigen 2;Thymic shared antigen 1
Sequence
MKIFLPVLLAALLGVERASSLMCFSCLNQKSNLYCLKPTICSDQDNYCVTVSASAGIGNL
VTFGHSLSKTCSPACPIPEGVNVGVASMGISCCQSFLCNFSAADGGLRASVTLLGAGLLL
SLLPALLRFGP

    Click to Show/Hide
Function
GPI-anchored cell surface protein that regulates T- lymphocytes proliferation, differentiation, and activation. Regulates the T-cell receptor (TCR) signaling by interacting with component CD3Z/CD247 at the plasma membrane, leading to CD3Z/CD247 phosphorylation modulation. Restricts the entry of human coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2, by interfering with spike protein-mediated membrane fusion. Also plays an essential role in placenta formation by acting as the main receptor for syncytin-A (SynA). Therefore, participates in the normal fusion of syncytiotrophoblast layer I (SynT- I) and in the proper morphogenesis of both fetal and maternal vasculatures within the placenta. May also act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity.

    Click to Show/Hide
Uniprot Entry
LY6E_HUMAN
HGNC ID
HGNC:6727
KEGG ID
hsa:4061
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-gD-LC-K149C
ADC Info ADC Name Payload Target Linker Ref
Alpha-gD-LC-K149C-10
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
[1]
Anti-Ly6E antibody
ADC Info ADC Name Payload Target Linker Ref
m7437
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Anti-Ly6E-LC-K149C
ADC Info ADC Name Payload Target Linker Ref
Alpha-Ly6E-LC-K149C-11
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
[1]
MLYE4489A
ADC Info ADC Name Payload Target Linker Ref
RG7841
MMAE
Microtubule (MT)
Mc-Val-Cit-PABC
Thio hu Anti-Ly6E 9B12.v12 LC K149C
ADC Info ADC Name Payload Target Linker Ref
WO2016205176A1 ADC-101
WO2016205176A1_ADC-101 payload
Undisclosed
WO2016205176A1_ADC-101 linker
[2]
WO2016205176A1 ADC-102
WO2016205176A1_ADC-102 payload
Undisclosed
WO2016205176A1_ADC-102 linker
[2]
WO2016205176A1 ADC-103
WO2016205176A1_ADC-103 payload
Undisclosed
WO2016205176A1_ADC-103 linker
[2]
WO2017059289A1 ADC-115
WO2017059289A1_ADC-115 payload
Undisclosed
WO2017059289A1_ADC-115 linker
[3]
WO2017059289A1 ADC-210
WO2017059289A1_ADC-210 payload
Undisclosed
WO2017059289A1_ADC-210 linker
[3]
WO2017214024A1 ADC-107
WO2017214024A1_ADC-107 payload
Undisclosed
WO2017214024A1_ADC-107 linker
[4]
WO2017214024A1 ADC-109
WO2017214024A1_ADC-109 payload
Undisclosed
WO2017214024A1_ADC-109 linker
[4]
Thio hu Anti-Ly6E LC K149C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-212
WO2017059289A1_ADC-212 payload
Undisclosed
WO2017059289A1_ADC-212 linker
[3]
undisclosed
ADC Info ADC Name Payload Target Linker Ref
ZW327
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
[5]
References
Ref 1 Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. Bioconjug Chem. 2019 May 15;30(5):1356-1370. doi: 10.1021/acs.bioconjchem.9b00133. Epub 2019 Apr 22.
Ref 2 Antibodies and immunoconjugates; 2016-12-22.
Ref 3 Pyrrolobenzodiazepine antibody drug conjugates and methods of use; 2017-04-06.
Ref 4 Silvestrol antibody-drug conjugates and methods of use; 2017-12-14.
Ref 5 ZW327, a novel Ly6E-targeting antibody-drug conjugate bearing a topoisomerase 1 inhibitor payload